Go to content
UR Home

Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor

URN to cite this document:
urn:nbn:de:bvb:355-epub-211804
Kist, A. ; Ho, A. D. ; Räth, U. ; Wiedenmann, B. ; Bauer, A. ; Schlick, E. ; Kirchner, H. ; Männel, Daniela N.
[img]
Preview
PDF
(996kB)
Date of publication of this fulltext: 20 Jun 2011 06:14


Abstract

Tumor necrosis factor (TNF), a protein predominantly produced by activated macrophages/monocytes, is presently available in recombinant, purified form for clinical trials. Intensive studies in many laboratories have shown that besides the tumorcytotoxic effects, TNF acts on a large array of different cells and has potent immunomodulatory activities. In a clinical phase I study, some immunologic ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons